Conformation of Molecular Weight of Intact Proteins by Single Quadrupole Mass Spectrometer

Significance of the topic

The determination of intact protein molecular weight is a cornerstone technique in biopharmaceutical development and quality control. Rapid and reliable confirmation of protein mass supports identity verification, synthesis confirmation, batch release, and impurity screening. While high-resolution mass spectrometers give the most accurate masses, this study demonstrates that a user-friendly single quadrupole LC–MS combined with modern deconvolution software can provide sufficiently precise molecular-weight confirmation for many routine QC and development tasks.

Objectives and overview of the study

The goal of the reported work was to evaluate whether a single quadrupole mass spectrometer (LCMS-2050) coupled to a Nexera X3 HPLC can confirm the molecular weights of intact proteins when supported by deconvolution software (LabSolutions Insight Biologics). The study analyzed three commercially available protein standards (myoglobin, carbonic anhydrase, and β-casein), processed multiply-charged ion spectra with the ReSpect algorithm, and assessed whether the resulting deconvoluted masses are suitable for synthesis confirmation and impurity detection in routine applications.

Used instrumentation

• Nexera X3 high-performance liquid chromatograph.
• LCMS-2050 single quadrupole mass spectrometer (ESI/APCI DUIS, positive ion mode).
• Shim-pack Scepter C4-300 analytical column (50 mm × 2.1 mm I.D., 3.0 µm).
• LabSolutions Insight Biologics software with the ReSpect multiply-charged ion deconvolution algorithm.

Methodology and analysis conditions

The proteins were prepared from commercial standards and diluted in ultrapure water. Chromatographic separation used a C4 reversed-phase column at 40 °C with a 0.4 mL/min flow and a gradient from 5% to 60% acetonitrile (both mobile phases acidified with 0.1% formic acid). Injection volume was 5 µL.

MS acquisition parameters were set to capture multiply charged species common for intact proteins: ESI positive mode, interface voltage ~3.0 kV, m/z scan range 500–2000, with heated desolvation (450 °C) and nebulizing/drying/heating gas flows adjusted to facilitate ionization and desolvation. Spectra of chromatographic peaks were deconvoluted using LabSolutions Insight Biologics (ReSpect) to reconstruct zero-charge (neutral) mass spectra from the observed charge envelopes.

Samples

• Myoglobin (equine skeletal muscle)
• Bovine carbonic anhydrase (red blood cells)
• β-Casein (bovine milk)

Main results and discussion

• Myoglobin: The multiply-charged envelope in the m/z 600–1400 range produced a deconvoluted mass of approximately 16949 Da, consistent with the expected intact myoglobin mass.
• Bovine carbonic anhydrase: Charge series observed across higher charge states gave a reconstructed mass near 29020 Da, in agreement with the protein standard's nominal mass.
• β-Casein: Two chromatographic peaks were detected and, after combining charge states and isotopic information, the deconvolution returned two close masses (~24088 and ~23979 Da), illustrating detection of proteoforms or processing variants/impurities.

Key observations: the single quadrupole instrument reliably recorded multiply-charged ion series for intact proteins within the selected m/z window, and LabSolutions Insight Biologics provided clear visualizations (component chromatograms, overlaid charge-state chromatograms, and deconvoluted spectra) that facilitate rapid mass confirmation and identification of multiple components. The approach is particularly useful when the expected main components are known in advance (e.g., specification-driven QC). Limitations include lower mass accuracy and resolution compared with high-resolution MS, which can matter for subtle mass differences (post-translational modifications, small truncations) or unknown complex mixtures.

Benefits and practical applications

• Fast molecular-weight confirmation for intact proteins in synthesis verification and routine QC workflows.
• Simple operation and data interpretation via integrated software that overlays charge states and reports deconvoluted masses visually, aiding non-expert users.
• Capability to detect multiple proteoforms or impurities by combining chromatographic separation with charge-state deconvolution.
• Cost-effective alternative to high-resolution MS for many routine applications where exact sub-dalton accuracy is not required.

Future trends and potential applications

• Software advances: improved deconvolution algorithms and AI-assisted interpretation will increase confidence in mass assignments from lower-resolution instruments.
• Workflow integration: automated sample handling and reporting for regulated QC environments will expand single-quadrupole applicability.
• Hybrid approaches: combining rapid single-quadrupole screening with targeted high-resolution follow-up for ambiguous or critical samples optimizes throughput and accuracy.
• Broader use in biopharma: intact-protein screening for biosimilar comparability, stability studies, formulation development, and impurity profiling.
• Native and top-down extensions: as ionization and interface technologies evolve, more structural information may be retrievable even on compact MS platforms.

Conclusion

The study demonstrates that a single quadrupole LC–MS (LCMS-2050) paired with LabSolutions Insight Biologics can provide reliable molecular-weight confirmation for intact proteins in many routine settings. While not a replacement for high-resolution mass spectrometry when the highest mass accuracy or structural resolution is required, this combination is a practical, cost-effective solution for synthesis confirmation, basic proteoform detection, and QC tasks where expected components are known.

References

• Analysis of Oligonucleotide Impurities Using Single Quadrupole Mass Spectrometer, Application News No. 01-00974-EN.
• Shimadzu Corporation. Application News: Conformation of Molecular Weight of Intact Proteins by Single Quadrupole Mass Spectrometer. Document No. 01-01023-EN, First Edition Jan. 2026.